Skip to main content
Journal of Neurophysiology logoLink to Journal of Neurophysiology
. 2014 Aug 13;112(10):2357–2373. doi: 10.1152/jn.00031.2014

Elevated serotonergic signaling amplifies synaptic noise and facilitates the emergence of epileptiform network oscillations

Pavel A Puzerey 1, Michael J Decker 2, Roberto F Galán 1,
PMCID: PMC4233266  PMID: 25122717

Abstract

Serotonin fibers densely innervate the cortical sheath to regulate neuronal excitability, but its role in shaping network dynamics remains undetermined. We show that serotonin provides an excitatory tone to cortical neurons in the form of spontaneous synaptic noise through 5-HT3 receptors, which is persistent and can be augmented using fluoxetine, a selective serotonin re-uptake inhibitor. Augmented serotonin signaling also increases cortical network activity by enhancing synaptic excitation through activation of 5-HT2 receptors. This in turn facilitates the emergence of epileptiform network oscillations (10–16 Hz) known as fast runs. A computational model of cortical dynamics demonstrates that these two combined mechanisms, increased background synaptic noise and enhanced synaptic excitation, are sufficient to replicate the emergence fast runs and their statistics. Consistent with these findings, we show that blocking 5-HT2 receptors in vivo significantly raises the threshold for convulsant-induced seizures.

Keywords: 5-HT2 receptors, 5-HT3 receptors, synaptic noise, cortical network dynamics, epileptic seizures


various neurotransmitter systems converge onto the neocortex to regulate the activity of cortical neurons in a process known as neuromodulation (Kaczmarek and Levitan 1987). Through the regulation of neuronal excitability, neuromodulation shapes the patterning of neural activity (Gil et al. 1997; Puig et al. 2010). Of the gamut of neuromodulators, serotonin [5-hydroxytryptamine (5-HT)] exerts a powerful influence on cortical neurons owing to an extensive distribution of 5-HT receptors (Dougherty and Aloyo 2011; Nichols and Nichols 2008; Santana et al. 2004) juxtaposed with dense innervation by serotonergic axons from the midbrain (Blue et al. 1988). In cortical neurons, metabotropic 5-HT2 and ionotropic 5-HT3 receptors (5-HT2Rs and 5-HT3Rs) are the primary mediators of excitatory responses to 5-HT (Nichols and Nichols 2008; Roerig et al. 1997; Tanaka and North 1993). The effects of these receptors are well characterized at the level of intrinsic neuronal and synaptic excitability (Araneda and Andrade 1991; Fink and Gothert 2007; Zhou and Hablitz 1999). However, the consequences of these effects on cortical network dynamics remain largely unexplored (Puig and Gulledge 2011).

Cortical network activity emanates from complex interactions between synaptic inputs (Economo and White 2012; Fernandez et al. 2013) and cell-intrinsic excitability (Grashow et al. 2010; Kolind et al. 2012); both are subject to neuromodulation (Araneda and Andrade 1991; Gil et al. 1997). The temporal dynamics of such activity vary between irregular (Shadlen and Newsome 1998) and oscillatory (Buzsaki and Draguhn 2004) patterns of activation, which may coexist simultaneously (Burns et al. 2011; Frohlich et al. 2010; Hansel 1996) or under different operational modes within a network (Poulet and Petersen 2008). Investigation of the invertebrate nervous system has revealed that network dynamics are reconfigured with neuromodulation to switch between distinct dynamical regimes, resulting in changes to behavior (Marder 2012). Complementary findings in vertebrates remain scarce. Despite recent advances in understanding the role of 5-HT in regulation of cortical network activity (Andrade 2011; Celada et al. 2013; Nakamura and Wong-Lin 2014; Puig and Gulledge 2011), comprehensive evidence is still lacking owing to serotonin's complex and combinatorial effects on neuronal excitability.

Theoretical studies have suggested that network dynamics are sensitive to random fluctuations of synaptic conductances or, in other words, synaptic “noise” (Parga and Abbott 2007; Stacey et al. 2009). Introduction of randomly fluctuating synaptic inputs to simulated neuronal networks facilitates transitions between distinct network states (Destexhe et al. 2001; Frohlich et al. 2010), but to date there is little empirical evidence for this. Within the neocortex, synaptic noise emerges from spontaneous release of synaptic vesicles (Otsu and Murphy 2003; Wasser and Kavalali 2009). Based on the theoretical considerations, we sought to understand how 5-HT contributes to synaptic noise in the cortex and, more specifically, how this serotonergic tone influences network excitability and network oscillations.

Here we show that synaptic noise can be augmented with the antidepressant fluoxetine (FLX), resulting in enhanced cortical network activity. Importantly, the increase in synaptic noise is accompanied by the emergence of epileptiform cortical dynamics that arise from a 5-HT2R-dependent enhancement of synaptic excitatory coupling. Using computational simulations, we demonstrate that enhanced synaptic excitation and noise are sufficient to account for the observed dynamics. In accord with these findings from in vitro experiments, we show that blocking 5-HT2Rs in mice significantly delays the onset of convulsant-induced epileptic seizures in vivo and may even completely prevent them.

MATERIALS AND METHODS

All experimental protocols were approved by the Institutional Animal Care and Use Committee at Case Western Reserve University.

Thalamocortical slice preparation.

Thalamocortical slices (350 μm) of somatosensory cortex were prepared as previously described from juvenile [postnatal days 13–21 (P13–21)] C57BL/6 wild-type mice (Agmon and Connors 1991; Pucilowska et al. 2012). Animals were anesthetized with vapor isoflurane and decapitated with a guillotine. The brain was then submerged in ice-cold artificial cerebrospinal fluid (ACSF) saturated with 95% O2/5% CO2 containing the following: 125 mM NaCl, 2.5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 25 mM NaHCO3, 1.25 mM NaH2PO4, and 25 mM glucose. Brain slices were cut on a vibratome (Leica VT1200). All chemical salts and reagents were purchased from Fisher Scientific (Pittsburgh, PA) and Sigma-Aldrich (St. Louis, MO). After the vibratome, slices were transferred to a bath containing room temperature ACSF for 20 min to incubate. Subsequently, slices were moved to the recording chamber and perfused with standard ACSF warmed to 31°C with a TC-324B Automatic Temperature Controller (Warner Instrument, Hamden, CT) at a rate of 2 ml/min. Slices were then incubated for 1 h before beginning electrophysiological recordings.

In vitro electrophysiology.

Pyramidal cells within L2/3 were visually identified at ×63 magnification using Kohler illumination with an upright microscope (Zeiss Axioskop 2 FS+). Whole-cell patch-clamp recordings under the current-clamp configuration were established in single neurons using borosilicate glass electrodes (6–10 MΩ) filled with standard internal solution containing the following: 120 mM potassium-gluconate, 2 mM KCl, 10 mM HEPES, 10 mM sodium phosphocreatine, 4 mM MgATP, 0.3 mM Na3GTP, 25 mM QX314, and adjusted to pH 7.4 with KOH. For voltage-clamp recordings, a cesium-based internal solution was used to improve space clamp and contained the following: 120 mM cesium-gluconate, 2 mM CsCl, 10 mM HEPES, 10 mM sodium phosphocreatine, 4 mM MgATP, 0.3 mM Na3GTP, 20 mM BAPTA, and 25 mM QX314 to block voltage-gated sodium channels and adjusted to pH 7.4 with CsOH. Voltage- and current-clamp experiments were performed using Multiclamp 700B amplifier (Molecular Devices, Foster City, CA) digitized at 10 kHz with Digidata 1400 data acquisition interface. The data was low-pass filtered online at 1 kHz.

Spontaneous excitatory postsynaptic currents (sEPSCs) were recorded in the voltage-clamp configuration for 60 s. To isolate the excitatory synaptic currents, the membrane potential of the neuronal membrane was biased to the reversal potential for inhibitory postsynaptic currents, which was experimentally determined to be −80 mV, consistent with previous reports (Chagnac-Amitai and Connors 1989; Hasenstaub et al. 2005). Recordings were excluded if access resistance exceeded 30 MΩ throughout the duration of the recordings and/or if the resting membrane potential was more positive than −60 mV. All pharmacological agents were washed into the bath. The slices were then given 1 h to incubate before beginning recordings.

Current-clamp recordings were performed to assess cortical network activity in a disinhibited slice preparation. To partially disinhibit the cortical network, the ACSF was modified to contain 1 μM gabazine (GZN), a selective GABAA receptor antagonist. Under control conditions, spontaneous network activity appeared as paroxysmal depolarizing shifts (PDS), which had a stereotypical voltage profile containing an initial plateau depolarization (∼60–80 mV relative to baseline) lasting 400–500 ms, succeeded by a decaying tail lasting ∼500 ms. Recordings of cortical network activity lasted 10 min and were obtained without current injection (holding current = 0 pA). The concentration of GZN was chosen so to elicit on average one to two PDS per minute, thus making the recordings amenable to statistical analysis. At this concentration, the network was not sufficiently disinhibited to spontaneously exhibit fast-run epileptiform oscillations.

Sampling from individual animals for slice experiments involved taking one slice per animal and recording from five to seven cells from each slice. No more than one pharmacological challenge was presented to a given slice. Statistical tests were carried out on groups of 30–40 cells (corresponding to 5–6 animals/group).

Data analysis and statistics.

sEPSCs were detected using a custom algorithm written and implemented in Matlab (Mathworks). Detection was based on a threshold for the sEPSC derivative with threshold values for events obtained empirically. sEPSC detection also included criteria for event kinetics. Events with rise time longer than 5 ms and decay time constant longer than 30 ms were excluded; also the rise time was not allowed to exceed the decay time constant. Events were visually inspected after being subjected to the exclusion criteria to ensure they exhibited the typical profile of an alpha function. Network events in current-clamp were detected manually using a custom interactive program written in Matlab. Voltage deflections during PDS network activity typically were between 50 and 80 mV, depending on the resting potential of the neuron (typically approximately −70 mV), and thus could be detected easily by a simple amplitude threshold-based detection. Reverberant afterdischarges during fast runs were detected by setting an absolute amplitude threshold of 30 mV relative to the resting potential and a 10-mV threshold relative to the local minimum (i.e., if the voltage deflection occurred on top of a depolarization plateau). Network-mediated postsynaptic currents (nEPSCs) were detected using an automated custom script in Matlab that detected currents larger than 100 pA. In the instance of reverberant network currents, the first current in a single network event always exceeded 1 nA and was substantially larger than the succeeding currents. Thus, to separate the first event from the smaller reverberant currents, we used an amplitude threshold of 1 nA. This procedure allowed us to separate the initial network current (i.e., the trigger event) and the sequential afterdischarges (i.e., reverberant currents). We determined statistically significant differences between distributions using the nonparametric Wilcoxon rank-sum test, which tests the null hypothesis that two independent groups of samples come from distributions with equal medians.

Spectral analysis.

To compute the power spectrum of PDS, we first convert the membrane potential traces into a series, s(t), of discrete events

s(t)=p=1Nδ(ttp) (1)

where δ(x) is Dirac's delta function, t is time, tp denotes the time of the pth PDS onset, and N denotes the number of PDS in 10 min. The Fourier transform [denoted with a tilde (˜)] of Eq. 1 yields

s˜(ω)=12πs(t)exp(iωt)dt=12πp=1Nexp(iωtp)

where i is the imaginary unit, and ω is the angular frequency. The power spectrum, P, is then given by

P(ω)=s˜(ω)2=12πp=1Nq=1Nexp[iω(tptq)]=N2π+1πp>qNq=1Ncos[ω(tptq)] (2)

Equation 2 is computed for each cell and then averaged for all cells recorded under the same conditions (more than 30 in each group). Note that at ω = 0 the power is N2/(2π). Moreover, for stochastic binary processes, as ω → ∞, the power converges to the baseline N/(2π). The x-axis in Fig. 2F shows the linear frequency, f = ω/(2π).

Fig. 2.

Fig. 2.

Elevated endogenous 5-HT in cortical slices enhances network excitability and transforms network dynamics. AE: raw traces of network activity recorded over 10 min from L2/3 pyramidal cell (PC) in a disinhibited cortical slice under control conditions (GZN only) (A), with FLX (B), with FLX and GSN (C), with FLX and ketanserin (KSN; D), and with FLX and 8-hydroxy-2-(dihydropylamino)tetralin (8-OH-DPAT; E). Top trace represents entire recording, and bottom trace zooms in on a single network event. Note that, in A and D, network activity manifests as isolated paroxysmal depolarizing shifts (PDS), while in B and C it appears as oscillatory fast runs. F: box plots of the number of network bursts observed per recording for the four groups (control: n = 30; FLX: n = 31; FLX+GSN: n = 31; FLX+KSN: n = 29; FLX+8-OH-DPAT: n = 27). Asterisks above distributions denote level of significance (*P < 0.05; **P < 0.01, n.s. = not significant). G: power spectrum obtained from recordings of network activity exemplified in AE. Baseline of power spectrum corresponds to the baseline level of network activity in each group.

Computational model.

The model consists of an excitatory neuron coupled to an inhibitory neuron, as depicted in Fig. 4A. The model also includes recurrent excitation and inhibition. The rate of change of the membrane potential for each neuron obeys the equation C·dV/dt = −Itotal, where C is the membrane capacitance, V is the membrane potential, and Itotal is the total current, i.e., the sum of all membrane and synaptic currents. We first note that, during a PDS, the current is completely dominated by synaptic currents; in other words, the neurons are in a high-conductance state. Similarly, in the absence of PDS, the neurons are close to their resting potential whose fluctuations are dominated by synaptic noise. Consistent with these observations, all voltage-gated membrane currents can be neglected for the purpose of this study. We thus have that the total current consists of an excitatory and inhibitory component. The excitatory component is mediated by dl-α-amino-3-hydroxy-5-methylisoxazole-propionic acid (AMPA) and N-methyl-d-aspartate (NMDA) currents, whereas the inhibitory component is mediated by GABAA current and by a slow outward K+ current, similar to the slow afterhyperpolarizing current (IsAHP) (Andrade et al. 2012; Villalobos et al. 2005). In addition, there is a leak current and synaptic noise in the form of mixed excitatory and inhibitory barrages. The total current takes then the form: ItotalIAMPA + INMDA + IGABAA + IsAHP + Ileak + Inoise. The parameters for all of these currents are defined below, and their values are listed in Table 1. The functional form of the AMPA, GABAA, and sAHP currents is the same, Ik = Gk(t)(VEk), where the subindex k refers to the current type, Gk(t) is the time-dependent synaptic conductance, as explained below, V is the postsynaptic membrane potential, and Ek is the reversal potential for that synapse type. The time dependence of the synaptic conductances is modeled as a double low-pass filter so that the impulse-response is the well-known “alpha function.” Specifically, the integration of the synaptic dynamics is given by

{τkdFkdt=Fk+gkH(Vpreθ)τkdGkdt=Gk+Fk

where Fk is an intermediate integration variable accounting for the synaptic decay, Vpre is the membrane potential of the presynaptic neuron, θ is the voltage threshold for the presynaptic neuron to release neurotransmitter, gk is the maximal synaptic conductance, and τk is the synaptic time constant (see Table 1). The function H(xa) is the Heaviside function; its value is 1 when x > a and 0 otherwise. The functional form of the NMDA current contains the additional factor depending on the membrane potential, B(V) = 1/[1 + 0.7exp (−V/16.13)], which accounts for the Mg2+-blockade of NMDA receptors dependent on the postsynaptic membrane potential: INMDA = GNMDA(tB(V)·(VEk), where GNMDA denote the total conductance of NMDA receptors. The leak current has the form Ileak = gL(VEL), where the leak conductance, gL, and reversal potential, EL, are constant. The synaptic noise has two independent contributions, both excitatory: 1) small-amplitude noise; and 2) large-amplitude noise. The former is responsible for fluctuations of the membrane potential that at rest are not sufficient to cause large depolarizations. The latter is responsible for large but infrequent membrane potential depolarizations. Both noises are modeled as Poisson processes that are statistically independent from each other. The small noise impinges also independently on the excitatory and inhibitory neurons, whereas the large noise impinges on the excitatory neuron only. The events of the Poisson process are processed through a double low-pass filter to model the kinetics of synaptic noise. The rates of the Poisson processes, λ; the peak amplitudes of the events, g; and their time constants, τ, are listed in Table 1.

Fig. 4.

Fig. 4.

Computational model accounts for emergence of fast runs with increased synaptic noise and excitatory coupling. A: cortical microcircuit of layer 2/3 and reduction to its core motif. Gray triangles represent cortical pyramidal neurons, while gray circles represent cortical interneurons. Excitatory connections are denoted by arrowheads and inhibitory connections by small circles. B: dependence of the total current on the membrane potential at the three phases of the PDS. The straight dashed line corresponds to the low-conductance state preceding a PDS. During this state, the membrane potential dynamics are dictated by the leak conductance. The curved solid line corresponds to the early phase of the PDS and is equivalent to the high-conductance state, during which synaptic conductances dominate the membrane potential dynamics. The curved dashed line corresponds to the late phase of the PDS during which slow inhibitory conductance competes with fast excitation to repolarize the membrane potential. I, current; C, membrane capacitance. C: PDS generated by the model. D: PDS turn into fast runs when synaptic excitation is increased. Iexc, excitation current. E: increasing the leak current (Ileak) in the presence of enhanced synaptic excitation prevents generation of fast runs, recapitulating in vitro results with FLX + 8-OH-DPAT. F: decreasing the slow afterhyperpolarizing current (IsAHP) generates fast run oscillations. G: box plot of the number of network events under control conditions (control; n = 30 trials), under increased synaptic noise and synaptic excitation (FLX; n = 30 trials), under increased synaptic excitation and moderate synaptic noise (FLX+GSN; n = 30 trials), under increased synaptic excitation and enhanced Ileak (FLX+DPAT; n = 30 trials), and under decreased IsAHP (n = 30 trials). Inoise, noise current. The model replicates the statistics of network bursts from the experiments in Fig. 2F. *P < 0.05. **P < 0.01.

Table 1.

Parameters of the computational model

Parameter Value
C 50 pF
gAMPA 2.5 pS
gNMDA 240 → 260 pS
gGABAA 37.5 pS
gAHP 3.75 → 7.5 pS
gL 5 → 5.125 pS
τAMPA 5 ms
τNMDA 10 ms
τGABAA 10 ms
τAHP 30 ms
EAMPA 15 mV
ENMDA 15 mV
EGABAA −80 mV
EAHP −75 mV
EL −75 mV
θ −35 mV
λ−1 (small noise) 2 ms
λ−1 (large noise) 5,000 ms
g (small noise) 1.25 → 2.5 → 3.75 pS
g (large noise) 250 pS
τ (small noise) 2.5 ms
τ (large noise) 2.5 ms

Subscripted acronyms denote the receptor or ion-channel type for the conductance (g), time constant (τ), or reversal potential (E); AMPA, dl-α-amino-3-hydroxy-5-methylisoxazole-propionic acid; NMDA, N-methyl-d-aspartate; AHP, afterhyperpolarizing; C, membrane capacitance; gL, leak conductance; θ, voltage threshold for the presynaptic neuron to release neurotransmitter; λ, rates of the synaptic noise. Arrows indicate the change of parameters used for Fig. 4G.

Seizure induction.

Juvenile C57BL/6 mice (P18–24) were administered the convulsant, pentetrazol (PTZ; 80 mg/kg ip) dissolved in 0.1 M phosphate-buffered saline (PBS). Some animals were treated with ketanserin (KSN; 5 mg/kg ip) dissolved in 5% DMSO 0.1 M PBS solution 1 h prior to PTZ injection, and a control group was pretreated with DMSO solution alone to exclude the potential effect of the drug vehicle in modulating seizure parameters. Control animals were not subsequently used in testing the effects of KSN. The starting point of behavioral seizures was considered as the appearance of generalized clonic convulsions with loss of righting reflex (GCC-LOR). The endpoint for each GCC-LOR seizure was considered as either complete release from tonus (in animals presenting with tonus), or as cessation of generalized clonic convulsions and recovery of righting (Loscher et al. 1990). The time elapsed between PTZ injection and the first GCC-LOR seizure was taken as the seizure latency. Time elapsed between each subsequent seizure was considered to be the interseizure interval. In the majority of acute seizure experiments, the animal died after experiencing several seizures. If the seizures persisted for over 1 h after PTZ injection, the animals were euthanized by isoflurane anesthesia and decapitation. Animals that did not experience seizures within 1 h after PTZ injection were not included in the data analysis. For the electroencephalagrophy (EEG) recordings (see next section), the time limit for the experiment was extended to 2 h.

In vivo electrophysiology.

We obtained EEG recordings of PTZ-induced seizures from 13 juvenile (P20–24) C57BL/6 mice. Using techniques described elsewhere (Berkeley et al. 2002; Papale et al. 2013), we implanted a fine-wire EEG recording electrode (Vintage Machine Supplies, Medina, OH) subdurally over somatosensory cortex, and a reference electrode was placed over the ipsilateral sensorimotor cortex. The tip of the electrodes (∼1 mm) was fed through two small holes in the parietal bone of the calvarium and positioned parallel to the surface of the cortex. Postsurgical pain management was maintained with bupivacaine (2 mg/kg sc every 12 h) and carprofen (5 mg/kg sc every 24 h). Animals were allowed to recover 1–2 days before the seizure experiments were performed. EEG recordings were collected using a CP511 AC amplifier (Grass Technologies, Middleton, WI) using ×100 amplification. The raw signal was band-pass filtered online between 0.1 and 100 Hz and digitized at 1 kHz using a Power 1401 mkII data acquisition system (Cambridge Electronic Design, Cambridge, UK).

EEG recordings were then processed offline using Matlab. Raw EEG waveforms were mean-subtracted and passed through a Butterworth filter in the pass band of 8–16 Hz. This pass band was selected based on the relevant physiological frequencies of fast-run oscillations in vivo (Steriade et al. 1998). The onset of electrographic seizures was detected by rectifying and integrating the band-pass filtered EEG waveform with a time constant of τ = 5 s. An amplitude threshold was then set for the filtered and integrated EEG traces from individual animals due to the variable signal-to-noise ratios between different experiments. The latency to the first electrographic seizure was taken as the time from injection of convulsant to the first threshold crossing in the processed EEG signal.

Biocytin staining, histology, and imaging.

Layer 2/3 pyramidal cells (PCs) were filled with 20 mM biocytin (Sigma-Aldrich) during patch-clamp recordings. At the end of the experiments, slices were preserved in 0.1 M PBS solution containing 4% paraformaldehyde for over 24 h. Slices were then subjected to three washes in 0.1 M PBS solution containing 0.5% Triton X-100 for 15 min and left to incubate for 24 h in the same solution containing avidin-biotin complex (ABC Staining Kit, Elite Vector Laboratories). Slices were then washed three times in the PBS-Triton solution for 15 min and stained with a diaminobenzedine (DAB Peroxidase Substrate Kit, Elite Vector Laboratories) solution until desired staining intensity was achieved. Slices were rinsed three times for 10 min in 0.1 M PBS solution, followed by series of alcohol and xylene washes to dehydrate the tissue. Slices were stored in methyl salicylate. Stained neurons were visualized under bright-field illumination with ×20 and ×40 magnification using a Leica DM5000 B upright microscope and imaged with a Leica DFC420 C digital camera and Leica Application Suite imaging software. Images were further processed and refined using ImageJ (National Institutes of Health) graphics editing software.

RESULTS

Spontaneous synaptic activity in mouse neocortex is partially mediated by 5-HT in vitro.

As a first step to investigate the role of serotonin in cortical network excitability, we measured the contribution of serotonergic signaling to spontaneous synaptic activity in layer 2/3 PCs in thalamocortical slices of mouse somatosensory cortex (Agmon and Connors 1991). We chose somatosensory cortex as a target region owing to its distinct organization of neuronal populations into barrel columns, which are specialized for local (<300 μm) neuronal interactions and have a high degree of recurrent connectivity (Lefort et al. 2009; Petersen et al. 2003; Thomson and Lamy 2007). Pyramidal cell morphology was determined visually and verified post hoc with biocytin labeling (Fig. 1A). sEPSCs were recorded in voltage-clamp using a cesium-based internal solution while blocking glutamatergic synaptic transmission through AMPA and kainate receptors with 2,3-dyhydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione (NBQX; 10 μM). NMDA receptor contribution was eliminated by holding the cell at a holding potential (−80 mV) at which NMDA receptors are blocked by Mg2+ ions. We show that bath application of NBQX significantly reduced sEPSC amplitudes (P < 0.01, Wilcoxon rank-sum test; Fig. 1, B and C) and increased the interevent intervals (IEI) (P < 0.01; Wilcoxon rank-sum test; Fig. 1, B and D), but failed to eliminate all sEPSCs, consistent with previous reports implicating other neurotransmitters involved in spontaneous synaptic release (Pankratov et al. 2007; Roerig et al. 1997). We investigated 5-HT as a potential source of the NBQX-resistant sEPSCs based on a previous report showing 5-HT as a mediator of fast synaptic transmission in cortical PCs through 5-HT3 ionotropic receptors (5-HT3Rs) (Roerig et al. 1997). In agreement with that report, bath application of the 5-HT3R antagonist, granisetron (GSN; 1 μM), with NBQX resulted in a dramatic reduction of sEPSC amplitudes (P < 0.01, Wilcoxon rank-sum test; Fig. 1, B and C) and a substantial increase in the IEIs (P < 0.01, Wilcoxon rank-sum test; Fig. 1, B and D). To test whether the serotonergic component depends on neuronal firing, we coadministered tetrodotoxin (TTX; 1 μM), a voltage-gated sodium channel blocker, with NBQX and observed no significant difference in event amplitudes between events recorded in the presence of NBQX alone or with NBQX and TTX in tandem (P > 0.05; Wilcoxon rank-sum test; Fig. 1, B and C). The event amplitudes in the presence of NBQX and GSN together were significantly smaller than with NBQX and TTX (P < 0.01, Wilcoxon rank-sum test; Fig. 1, B and C). While no significant change in IEIs was observed between spontaneous activity recorded with NBQX and NBQX with TTX (P > 0.05, Wilcoxon rank-sum test; Fig. 1, B and D), there was a significant increase in IEIs recorded with NBQX and GSN compared with the group recorded with NBQX and TTX (P < 0.01, Wilcoxon rank-sum test; Fig. 1, B and D). This suggests that the fast ionotropic 5-HT3R signaling observed in cortical PCs arises independently of neuronal firing. Combined, these results indicate that 5-HT signaling through 5-HT3Rs significantly contributes to the NBQX-resistant component of the ongoing spontaneous synaptic activity in the mouse neocortex.

Fig. 1.

Fig. 1.

Spontaneous excitatory transmitter release is mediated in part by 5-hydroxytryptamine (5-HT3) receptors in mouse neocortex. A: images of biocytin-labeled pyramidal neurons in L2/3 of mouse somatosensory cortex. Right panel shows neurons under ×20 magnification with layer boundaries delineated by opaque white lines. Cortical laminae are labeled accordingly. Left panel shows neurons under ×40 magnification with a clear view of the apical dendrites projecting to L1, basal dendrites projecting laterally, and, in some neurons, the axon is visibly projecting toward the deeper layers. B: raw traces of spontaneous excitatory postsynaptic currents (sEPSCs) recorded under three conditions: 1) control (no drugs); 2) 10 μM 2,3-dyhydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione (NBQX) [dl-α-amino-3-hydroxy-5-methylisoxazole-propionic acid receptor (AMPAR) blockade]; and 3) 10 μM NBQX with 1 μM granisetron (GSN) [AMPAR and 5-HT3 receptor (5-HT3R) blockade]. C: cumulative distribution function of sEPSC amplitudes under three experimental conditions (control: n = 28; NBQX: n = 27; NBQX+GSN: n = 25). D: cumulative distribution function of sEPSC interevent intervals (IEIs) for the data presented in B. E: raw traces of sEPSCs recorded under: 1) control conditions; 2) 4 μM fluoxetine (FLX); 3) 4 μM FLX with 1 μM GSN; and 4) 5 μM m-chlorophenylbiguanide (mCPBG). F: cumulative distribution function of sEPSC amplitudes under the described experimental conditions (control: n = 28; FLX: n = 24; FLX+GSN: n = 29; mCPBG: n = 22). G: cumulative distribution function of sEPSC IEIs for the data presented in E. Note that the FLX and FLX+GSN distributions are overlapping. TTX, tetrodotoxin.

In line with this hypothesis, raising endogenous 5-HT levels should increase spontaneous synaptic activity. Indeed, bath application of the selective serotonin re-uptake inhibitor (SSRI), FLX (4 μM), dramatically augmented sEPSC amplitudes (P < 0.01, Wilcoxon rank-sum test; Fig. 1, E and F) and reduced the IEIs (P < 0.01; Wilcoxon rank-sum test; Fig. 1, E and G) relative to control. Coapplication of FLX and GSN substantially reduced the FLX-mediated increase in sEPSC amplitudes (P < 0.01, Wilcoxon rank-sum test; Fig. 1, E and F), but had no effect on the FLX-mediated decrease in IEIs (P > 0.05; Wilcoxon rank-sum test; Fig. 1, E and G). Note that the FLX and FLX+GSN IEI distributions are overlapping. To further verify that activating 5-HT3Rs increases the amplitude and rate of spontaneous synaptic activity in cortical PCs, we bath applied a 5-HT3R-specific agonist, m-chlorophenylbiguanide (mCPBG) and recorded sEPSCs. Indeed, administration of mCPBG resulted in a dramatic increase in the amplitude and frequency of sEPSCs in cortical neurons relative to control conditions (P < 0.01, Wilcoxon rank-sum test; Fig. 1, E, F, and G). The effect of mCPBG on sEPSC amplitude exceeded that of FLX (P < 0.01, Wilcoxon rank-sum test), but the effect on frequency was comparable (P > 0.05, Wilcoxon rank-sum test). One potential confound of these results is the possibility that incomplete voltage clamp across the somato-dendritic axis (i.e., incomplete space clamp) would result in contamination of sEPSCs with inhibitory GABAA receptor-mediated postsynaptic currents. This scenario is plausible considering that a large proportion of cortical inhibitory interneurons express 5-HT3Rs and could be activated by mCPBG to trigger spontaneous inhibitory postsynaptic currents in PCs (Lee et al. 2010; Morales and Wang 2002; Vucurovic et al. 2010). To control for this possible confound, in addition to using a Cs-based internal solution that minimizes space-clamp effects, we recorded the sEPSCs elicited by mCPBG in the presence of GZN (5 μM), a GABAA receptor-specific antagonist. If the sEPSCs recorded at the reversal potential for inhibition are contaminated by GABAergic currents due to incomplete space clamp, then GZN would lead to the abolition of these events. mCPBG coadministered with GZN did not lead to a reduction in sEPSC amplitude compared with mCPBG treatment alone, but modestly increased the IEI (data not shown), suggesting that although a small fraction of the recorded events may arise from GABAergic currents escaping voltage clamp, the majority of these events result from 5-HT3R signaling at the level of cortical PCs. This finding is consistent with the idea that spontaneous synaptic release, or synaptic noise, in the cortex is mediated in part by 5-HT signaling through 5-HT3Rs and offers a valuable tool to explore how altered serotonergic signaling affects network activity in cortical slices.

Augmenting endogenous 5-HT signaling transforms cortical network dynamics via 5-HT2Rs and 5-HT3Rs.

What are the consequences of increasing endogenous 5-HT levels on cortical network activity? To address this question, we employed a disinhibited slice preparation (Gutnick et al. 1982; Hablitz 1984) using bath application of the GABAA receptor antagonist, GZN (1 μM). In this paradigm, the normally quiescent cortical network initiates bursts of activity in the form of PDS (Fig. 2A). The PDS reflects synchronous activation of local cortical networks, thus enabling recordings from single neurons to probe network activity. The voltage profile of a PDS under a current-clamp recording configuration is characterized by a large and rapid depolarization (∼60–80 mV from baseline) lasting ∼0.5 s, followed by a tail that decays to baseline within 0.5–2 s (Fig. 2A). The power spectrum density of the voltage traces (see materials and methods) revealed that PDS events occur randomly in time, represented by a flat spectrum lacking frequency peaks, as shown in Fig. 2G (Control case). Occurrence of these events can thus be considered a stochastic process, reflecting a lack of temporal organization in cortical dynamics. To determine the effect of enhanced endogenous 5-HT signaling on network dynamics, we bath-applied FLX (4 μM) for the duration of the recordings and found that FLX dramatically increased the number of network bursts recorded in a 10-min interval relative to control conditions (P < 0.01, Wilcoxon rank-sum test; Fig. 2, B and F). Moreover, we show that enhanced serotonergic signaling transforms the patterning of cortical activity from temporally sparse and random to clustered and periodic network dynamics, as described below (Fig. 2B). These clusters of network activity have a voltage profile characterized by an initial long burst (∼500 ms), comparable to the PDS seen in control conditions, followed by a sequence of shorter afterdischarges (duration ∼40 ms) superposed on a long depolarizing plateau. The intracluster bursts occurred with a preferred frequency in the low beta range (10–16 Hz; Fig. 2, B and G), while intercluster intervals showed no temporal patterning. The shift in the baseline of the power spectrum in Fig. 2G corresponds to an increase in the total number of events, consistent with findings shown in Fig. 2F. Note that the afterdischarges are of synaptic origin and persist in the absence of spiking when the recorded neuron is filled with QX-314 to block voltage-gated sodium channels. This pattern of activity has been observed previously in disinhibited rat cortex in vivo and slices in vitro (Castro-Alamancos 2000; Castro-Alamancos and Rigas 2002), animal models of spontaneous epileptic seizures (Timofeev et al. 1998), as well as in certain forms of childhood onset epilepsies (Camfield 2011), and has been termed “fast runs,” a designation we will employ here.

FLX increases serotonergic signaling by blocking presynaptic reuptake of 5-HT, thereby increasing transmitter availability for postsynaptic receptors. Thus, if the alteration of cortical network activity observed here is a bona fide serotonergic phenomenon, then some 5-HT receptor(s) must be responsible for the effect. Our observation that 5-HT3Rs generate a significant portion of spontaneous synaptic noise prompted us to ask whether this enhanced noise in the presence of FLX can account for the observed changes in cortical network activity. Coapplication of GSN with FLX in disinhibited slices led to a significant reduction of the number of network events (P < 0.01, Wilcoxon rank-sum test; Fig. 2F), but did not eliminate the fast runs, the persistence of which is represented by the beta peak in the power spectrum (Fig. 2G). This finding suggested the involvement of another 5-HT receptor in the emergence of the oscillatory fast runs. 5-HT2Rs are densely expressed in the cortex (Santana et al. 2004) and mediate excitatory neuronal responses (Araneda and Andrade 1991; Tanaka and North 1993), making them a suitable candidate. We blocked 5-HT2Rs with KSN (10 μM) in the presence of FLX and reduced the total number of network events back to control levels (control vs. KSN; P = 0.13; Wilcoxon rank-sum test; Fig. 2F). Importantly, this led to complete attenuation of fast runs represented by the elimination of the 10- to 16-Hz peak in the power spectrum (Fig. 2G). This effect was tested with a gamut of 5-HT2R antagonists, which were all able to eliminate the fast runs, albeit with different effects on network excitability. These included ritanserin and glemanserin to selectively antagonize 5-HT2aRs, and RS-102,221 to antagonize 5-HT2cRs. Receptor antagonists targeting 5-HT2aR subtypes were more effective at reducing network excitability than those targeting the 5-HT2c subtype, with KSN being the most effective (data not shown). We also tested the effect of 5-HT1R activation on fast-run activity, owing to their dense expression in the cortex and their inhibitory effects on neuronal excitability via activation of K+ currents (Parks et al. 1998; Tanaka and North 1993). 5-HT1Rs were activated using the specific agonist 8-hydroxy-2-(dihydropylamino)tetralin (8-OH-DPAT; 4 μm) in the presence of FLX. 8-OH-DPAT treatment resulted in a pronounced reduction in the number of recorded network events relative to FLX treatment alone (P < 0.01, Wilcoxon rank-sum test; Fig. 2, E and F), an effect statistically indistinguishable from that seen in the presence of FLX and GSN. It also led to an almost complete abolition of the 10- to 15-Hz oscillation (Fig. 2, E and G), consistent with a slowing of network bursting seen in the voltage profile in Fig. 1E. In the presence of 8-OH-DPAT, the network bursts occurred either as single PDS events, or as pairs of bursts like those shown in Fig. 2E. These results suggest that 1) 5-HT1R activity exerts an inhibitory effect on cortical network activity by precluding the occurrence of fast-run depolarizations and reducing network bursting; and that, 2) in the presence of FLX alone, activation of 5-HT1Rs by endogenous 5-HT release is insufficient to prevent the occurrence of fast runs. Thus our findings show that elevating endogenous 5-HT leads to an increase in cortical network excitability and the emergence of epileptiform network oscillations. The former effect is mediated in part by 5-HT3Rs and 5-HT2Rs, while the latter effect is exclusively attributable to activation of 5-HT2Rs. These observations provide a novel insight into how altered serotonergic tone in the cortex leads to the transformation cortical network dynamics.

FLX enhances excitatory synaptic inputs mediating cortical network activity.

The current-clamp experiments used in the previous section provide a proxy for the network behavior at the level of neuronal output. Voltage-clamping, on the other hand, offers insight into the magnitude, structure, and pharmacology of the inputs arriving at cortical neurons during network activity. We sought to determine the network mechanisms underlying the emergence of fast runs by measuring the network-mediated synaptic inputs in L2/3 PCs during disinhibition-induced activity in voltage-clamp before and after FLX treatment. With GZN alone, excitatory network inputs manifested as massive currents (nEPSCs; Fig. 3A) that were presumably dominated by AMPA receptor-mediated currents (Lee and Hablitz 1991), since NMDA receptor contribution was eliminated by holding the cell at a command potential (−80 mV) at which NMDA receptors are blocked by Mg2+ ions. Addition of FLX (4 μM) altered the network inputs in the following way. As expected, each network event had two phases corresponding to the two phases of the voltage profile in Fig. 2B. The first phase consisted of a large nEPSC lasting ∼500 ms, followed by the second phase comprised of substantially smaller nEPSCs, which occurred at the same frequency as the fast runs seen in Fig. 2 (Fig. 3B). This latter phase has been previously demonstrated to arise from recurrent glutamatergic synaptic transmission, which is expressed strongly in the superficial cortical layers and can be unmasked with sufficient disinhibition (Castro-Alamancos and Rigas 2002). We found that the charge transferred to each cell per event, taken as the integral of the total synaptic current, was substantially increased (P < 0.05, Wilcoxon rank-sum test; Fig. 3C) after FLX treatment. This suggests that each cell received on average more synaptic excitation during a network event when FLX was present. Importantly, we compared the amplitude of the first nEPSC within each event between the two groups by setting a threshold that clearly separated the first and second phases. Our results show that the first nEPSC within each network event is significantly larger in the presence of FLX (P < 0.01, Wilcoxon rank-sum test; Fig. 3D). Since this massive event acts as a trigger for the subsequent 10- to 16-Hz afterdischarges, these findings suggest that a shift in favor of more synaptic excitation during the initial burst leads to increased network activity and the onset of reverberant oscillations within the cortical circuit. We tested this hypothesis in the following section.

Fig. 3.

Fig. 3.

Enhanced synaptic excitation onto cortical neurons underlies transformation of network dynamics in the presence of FLX. A and B: raw traces of network-mediated excitatory postsynaptic currents (nEPSCs) recorded over 10-min interval under control conditions (A) and with FLX (B). Note, traces in A and B were obtained from different slices. Top trace represents entire recording, and bottom trace zooms in on a single network event. C: box plot of excitatory charge transferred to cortical PCs during each network event under control and FLX conditions (control: n = 28; FLX: n = 26). *P < 0.05. D: cumulative distribution functions of the amplitude of the initial nEPSC during each network event under control and FLX conditions.

Enhanced excitatory coupling and synaptic noise are sufficient to simulate FLX-modulated network activity in a model of a cortical microcircuit.

Are the increased synaptic noise and enhanced excitatory coupling observed in vitro sufficient to account for the emergence of fast runs, or is it secondary to some unknown biophysical process? This question poses a technical problem, since precise tuning of synaptic excitation and noise in the slice is impractical. Therefore, we tested this question using a computational model of a cortical microcircuit.

To this end, we adopt a minimal modeling approach and focus on capturing the essential biophysical properties of neurons leading to realistic cortical dynamics. The inspiration for our model is taken from a previous computational study (Parga and Abbott 2007) showing that the key feature of cortical network dynamics is the bistability of the neurons' membrane potential, as explained below. Bistability can be attained by multiple combinations of the excitatory and inhibitory synaptic conductances (Grashow et al. 2010; Prinz et al. 2003) and hence does not critically depend on their specific values.

For our purposes, those network models (Parga and Abbott 2007) can be simplified by noting that cortical microcircuits can, to a good approximation, be considered translation invariant, i.e., the connectivity pattern repeats itself across cortical columns. Figure 4A depicts the connectivity for layer 2/3. Because PDS occur synchronously across PCs within at least 200 μm (data not shown), the study of the dynamics of the microcircuit can be reduced to its simplest structural motif, consisting of a PC and an interneuron (Fig. 4A, right). The inputs of the missing neighbors are compensated by proportionately scaling the recurrent excitation and inhibition so that the net synaptic currents are the same as they would be when embedded in the full circuit. When the membrane potential of the neurons fluctuates around the resting (low conductance) state, the dominant current is the leak, as shown in Fig. 4B (straight dashed line). During the early phase of the PDS, the current driving the membrane potential is dominated by the AMPA, NMDA and to a lesser degree by GABAA components (high-conductance state; early phase). The dependence of the current on the membrane potential is now given by the solid curved line which crosses I/C = 0 at three points. The two crossings with a positive slope denote transiently stable points of the membrane potential, endowing the network with bistable dynamics (i.e., low/high-conductance states). In the late phase of the PDS, inhibition becomes more dominant, and the membrane potential decays slowly (high-conductance state; late phase). The dependence of the current on the membrane potential is now given by the dashed curved line with only one stable point close to the resting potential, driving the neurons to repolarize quickly. It is important to note that, in the absence of synaptic noise, the neurons would never develop PDS. Noise is necessary to make the transition to a depolarized state. Once in the depolarized state, the recruitment of inhibition and decay of excitation bring the membrane potential back to the resting state. Figure 4C shows the connections of the motif in the control case, as well as its dynamics. Figure 4D depicts the motif with increased synaptic excitation, mimicking the effect of FLX shown in Fig. 2B. The activity pattern now switches into a fast-run mode in which network activation occurs repetitively at ∼15 Hz. How does the increase in synaptic excitation make a qualitative change in the dynamics? Figure 4B shows that, while the membrane potential decays, the dependence of the current on the membrane potential smoothly morphs from the solid curved line to the dashed curved line, mainly by moving upwards. In this process, the membrane potential switches from a bistable regime to a monostable regime. If the synaptic noise is strong enough on the verge of this transition, it will shift the curve back down, bringing the membrane potential again to a depolarized state. The slower the decay of the membrane potential, the more likely it is that synaptic noise will depolarize it again. By this mechanism, increased synaptic noise creates reverberant fast-run oscillations within circuit.

Figure 4G shows that the model replicates the experimental results shown in Fig. 2F. The first group corresponds to control conditions in which synaptic noise and excitatory coupling are kept at basal conditions. Network events within this group manifest as single PDS-like bursts (Fig. 4C). The second group mimics the effects of FLX: an increase in synaptic noise mediated by 5-HT3Rs and an increase in synaptic excitation by 5-HT2Rs. As in vitro, the total number of network events increases significantly relative to control (P < 0.01; Wilcoxon rank-sum test) and so does the variability in network excitability as seen by a substantially larger spread in the distribution. Importantly, under these conditions, the network events appear as fast-run-like oscillatory bursts with a frequency of ∼15 Hz. A third group models the effect of FLX in the presence of GSN, or equivalently the effect of increasing synaptic excitation with only a marginal increase in synaptic noise. Clearly, the reduction in synaptic noise alone reduces the excitability of the network, but does not bring it back to the control level, nor does it abolish fast-run-like oscillations.

To further validate the model's ability in predicting the effects of pharmacological manipulations presented in Fig. 2, we modeled the effects of 5-HT1R activation with 8-OH-DPAT, which in the slice had a combined effect of reducing network excitability and abolishing fast runs. This effect is consistent with its effect on neuronal excitability (Araneda and Andrade 1991), which results to a large extent from an increase in potassium conductance through G protein-coupled inwardly rectifying potassium channels that contribute to the resting leak conductance (Luscher et al. 1997). We thus simulated the postsynaptic effect of 5-HT1R activation in the presence of FLX by increasing the leak conductance in the excitatory neuron within the model, while maintaining high levels of synaptic excitation and noise. This manipulation was able to mimic the effect of 8-OH-DPAT in the slice in two ways: first, the number of network events dropped substantially relative to the group with increased synaptic excitation and noise alone (P < 0.01, Wilcoxon rank-sum test; Fig. 4G). This reduction in number of events was statistically indistinguishable from the one observed in the group-simulating effects of FLX and GSN (P = 0.14, Wilcoxon rank-sum test), reproducing the results observed in vitro. Second, the fast-run oscillation was replaced by single bursts or burst pairs, similar to those recorded in the slice (Fig. 4E), suggesting that a 5-HT1R-mediated enhancement of leak current is capable of suppressing network activity and epileptiform network dynamics.

5-HT2Rs are also known to inhibit outward potassium current mediating the slow afterhyperpolarization (IsAHP) in cortical neurons (Satake et al. 2008; Villalobos et al. 2005, 2011). To test whether inhibition of IsAHP in the model alone can simulate the effects of FLX observed in the slice, we reduced this current while keeping control levels of synaptic excitation. Surprisingly, reduction of the IsAHP generated the fast-run oscillation (Fig. 4F) and increased the number of network bursts to levels observed with increased synaptic excitation and noise (i.e., FLX group) (P = 0.87; Wilcoxon rank-sum test). These results suggest that a parallel mechanism mediated by 5-HT2R-dependent inhibition of IsAHP could potentially generate epileptiform fast runs similar to those seen under conditions of increased excitatory coupling. Whether FLX actually decreases IsAHP in the in vitro preparation remains an open question.

Combined together, these results support our hypothesis that increased synaptic noise and excitatory coupling resulting from altered 5-HT signaling are sufficient to account for the increased network excitability and emergence of epileptiform fast-run oscillations. The synaptic noise increases the likelihood of transitioning into a depolarized high-conductance state, while the enhanced synaptic excitation facilitates the emergence of oscillatory dynamics. Furthermore, the model predicts the effects of 5-HT1R agonist 8-OH-DPAT by manipulating one of its known targets, namely the potassium current controlling the resting membrane potential, and provides a parallel mechanism by which fast-run oscillations can be generated in the presence of elevated 5-HT tone, namely 5-HT2R-mediated inhibition of the slow afterhyperpolarization current. These results underscore the utility of reduced models of cortical circuits, which in our case is capable of reproducing the in vitro results and making accurate predictions about network behavior under various pharmacological manipulations without fine-tuning the model's parameters.

In vivo blockade of 5-HT2R activity delays behavioral and electrographic seizure onset and reduces seizure incidence.

Fast runs are not an epiphenomenon of the cortical slice preparation, but have been observed during spontaneous epileptic seizures in cats (Steriade et al. 1998; Timofeev et al. 1998) and are a hallmark of EEG recordings from children with Lennox-Gastaut syndrome, a childhood-onset encephalopathy (Camfield 2011). Based on the in vitro efficacy of KSN in abolishing fast runs, we hypothesized that blocking 5-HT2Rs before convulsant-induced seizures in mice may increase the threshold to epileptic seizures or modulate other seizure parameters. To test this hypothesis, we induced seizures in mice with the convulsant, PTZ (80 mg/kg ip), and measured the latency to the first seizure characterized by loss of righting and generalized clonic convulsions (GCC-LOR; Fig. 5A), as well as the duration of each seizure. Consistent with our hypothesis, mice that received an injection of KSN (10 mg/kg ip) 1 h prior to PTZ injection showed a more than fivefold increase in latency to the first GCC-LOR seizure (P < 0.01, Wilcoxon rank-sum test; Fig. 5B) compared with mice injected with the vehicle control. The duration of seizures was not significantly different (P = 0.59; Wilcoxon rank-sum test; Fig. 5C), suggesting that blockade of 5-HT2Rs in vivo raises the threshold to seizure onset, but does not affect its termination. Furthermore, KSN treatment reduced seizure incidence in mice (control: 100% seized, n = 17; KSN: 78% seized, n = 18; P = 0.058, Fisher exact test).

Fig. 5.

Fig. 5.

5-HT2R blockade increases seizure threshold in vivo. A: schematic of experimental design for convulsant-induced seizure protocol. Control mice are given pentetrazol (PTZ) injection alone, while the test group is given the KSN 1 h prior to PTZ injection. Lightning bolts represent appearance of spontaneous generalized clonic convulsions with loss of righting reflex seizures some time after PTZ injection. B: box plot of latency to first seizure in control and KSN conditions (control: n = 17; KSN: n = 14). **P < 0.01. C: box plot of mean seizure duration for each animal in control and KSN groups. D: raw traces of electroencephalographic (EEG) recordings of epileptic seizures obtained from mouse treated with PTZ alone (left) and those pretreated with KSN 1 h before PTZ injection (right). t = 0 corresponds to the time of PTZ injection. E: comparison of latency to the onset of behavioral and electrographic siezures. Dashed gray line corresponds to the identity line (x = y), and solid black line corresponds to the linear fit of the two variables (n = 12 mice). F: box plot of latency to the onset of 8–16 Hz (beta band) activity in the EEG during electrographic seizures in control and KSN-treated mice (control: n = 5 mice; KSN = 7 mice). *P < 0.05.

The acute behavioral seizures accompanied by loss of righting and generalized clonic convulsions are an indirect proxy for the oscillatory brain dynamics that beget them. To directly test whether fast-run oscillations occur during acute seizures in mice treated with PTZ and whether the behaviorally measured seizure latencies have a correspondence to the onset of such oscillatory regimes in the cortex, we implanted 12 mice with subdural electrodes over the surface of somatosensory cortex and recorded the cortical EEG during seizures, with and without pretreatment with KSN. Figure 5D shows raw EEG recordings from individual mice pretreated with the drug vehicle alone (left) or with KSN (right). As visible from both traces, the onset of cortical seizures corresponds to a massive increase in activity in the EEG signal relative to the preceding baseline. The two traces also show that the onset of electrographic seizures in the mouse pretreated with KSN is substantially delayed (latency = 1,765 s) compared with the control mouse (latency = 71 s). We filtered the EEG traces in the pass band of 8–16 Hz to capture the fast-run oscillations in the beta band, as done previously by others (Steriade et al. 1998), and then determined the latency to the emergence of fast runs using a simple threshold (see materials and methods). To ensure that the latencies to behavioral seizures are an accurate proxy for the emergence of electrographic fast runs, we compared the latencies to the behavioral seizures with the latency to the onset of 8- to 16-Hz oscillations in the EEG. Figure 5E shows a very close and highly significant pairwise correlation between behaviorally and electrographically measured seizure latencies (R = 0.9967, P < 0.01, Student's t-test). We thus proceeded to compare the latency to the onset of cortical fast runs between control and KSN-treated animals and observed a significant delay in the onset of fast runs after pretreatment with KSN (vehicle: n = 5, KSN: n = 7; P < 0.05, Wilcoxon rank-sum test; Fig. 5F), a finding consistent with the those shown in in Fig. 5B.

Thus, just as 5-HT2R blockade prevents the emergence of epileptiform fast runs in vitro, it is also able to prevent or delay the onset of epileptic fast runs in vivo, lending support to the idea that serotonergic signaling in a disinhibited cortex facilitates the emergence of epileptiform activity and providing evidence across synaptic, network, and behavior levels of observation.

DISCUSSION

Despite decades of investigation on the role of 5-HT in neuronal excitability, its effects on dynamics of cortical networks remain unclear (Celada et al. 2013). We sought to further this understanding by determining how changes in endogenous 5-HT affect cortical network dynamics. Our findings demonstrate that cortical neurons are persistently bombarded with spontaneous excitatory synaptic inputs mediated in part by 5-HT3Rs. This synaptic noise can be augmented with the SSRI, FLX, at concentrations close to those measured in medicated human patients (Bolo et al. 2000). This results in enhanced network excitability and the transformation from temporally random to transiently oscillatory network dynamics, i.e., from PDS to fast runs, a transition which is facilitated by 5-HT2Rs. We show that, in cortical slices, such a shift is accounted for by increased excitatory coupling between PCs. A computational model corroborates that increased synaptic noise and synaptic excitation are sufficient to explain the increased network excitability and transitions between both network regimes. Consistent with these results, blocking 5-HT2Rs in vivo prior to PTZ-induced convulsions significantly delays the onset of epileptic seizures and reduces seizure incidence. Together, our findings provide a potential mechanism for how altered 5-HT tone can bias cortical network activity to transition into an epileptiform state.

The prevailing view of spontaneous excitatory neurotransmitter release onto cortical neurons held glutamate as its chief mediator (Espinosa and Kavalali 2009; Maffei and Turrigiano 2008; Sutton et al. 2004; Vyleta and Smith 2011), overlooking the contribution of other neurotransmitters (Pankratov et al. 2007; Roerig et al. 1997). Our findings show that 5-HT3Rs contribute substantially to spontaneous activity in the form of background synaptic noise, providing cortical PCs with a considerable excitatory tone. What is the source of 5-HT in the slice preparation? While the cortical slice lacks the dorsal raphe nucleus (DRN) containing the forebrain-projecting serotonergic neurons, it preserves their dense projections to cortical neurons. These remaining axons are the putative source of endogenous 5-HT in our preparation and, based on results presented in Fig. 1, support spontaneous vesicle release.

It is important to mention that our results from Fig. 1 are in conflict with the presently held assumption that 5-HT3Rs are expressed exclusively on cortical inhibitory interneurons. The evidence for this assumption comes from several studies that definitively show robust 5-HT3R expression on cortical interneurons (Jakab and Goldman-Rakic 2000; Lee et al. 2010; Morales and Wang 2002; Puig et al. 2004; Vucurovic et al. 2010), but fail to detect expression of these receptors on the principal pyramidal neurons. While it is undeniable that a subclass of cortical interneurons express 5-HT3Rs, we posit that the evidence is inconclusive pertaining to their expression on PCs. We first draw attention to the study by Puig et al. (2004), which used in situ hybridization and immunohistochemistry to assess 5-HT3R expression in GABAergic interneurons of the rat prefrontal cortex (PFC). They report in their results that a minority of 5-HT3R-expressing cells did not express glutamic acid decarboxylase mRNA, a marker of inhibitory neurons, and reported unpublished results in which some of these cells expressed vesicular glutamate transporter 1 mRNA, a marker of glutamatergic neurons. The authors state that they “… cannot exclude that a minority of 5-HT3 receptor-positive cells are pyramidal neurons.” These results are consistent with those of Roerig et al. (1997), who were the first to show spontaneous and evoked 5-HT3R-dependent currents on PCs of the ferret cortex and carried out post hoc analysis of neuronal morphology to verify that both pyramidal and nonpyramidal neurons functionally expressed these currents. A study by Sung et al. (2000) used a transgenic mouse line in which 5-HT3R expression was driven in forebrain pyramidal neurons using the CamKII promoter to investigate the modulation of 5-HT3Rs by alcohol. Using patch-clamp recordings, they first report no 5-HT3R-dependent currents in most principal cells from wild-type animals; however, they mention in the results that 7 out of 48 recorded cells in wild-type mice showed evoked 5-HT3R-mediated currents. That is, 15% of the cells which presumably should not express 5-HT3Rs do, thus providing supporting evidence for expression of functional 5-HT3Rs on cortical pyramidal neurons.

Some of the studies addressing the molecular expression of 5-HT3Rs in the cortex, such is that of Lee et al. (2010), have employed transgenic mouse lines that express enhanced green fluorescent protein in 5-HT3a receptor-expressing neurons and were able to demonstrate enhanced green fluorescent protein expression that was confined to cortical neurons expressing glutamic acid decarboxylase, but not special AT-rich sequence-binding protein 2, a marker of cortical PCs. A similar finding was reported by Vucurovic and colleagues (2010). A critical caveat in these studies pertains to the subunit composition of 5-HT3Rs of which there are two types, 5-HT3a and 5-HT3b. 5-HT3Rs can exist as homomers composed of only 5-HT3a subunits (Brown et al. 1998) or as heteromers containing both subunit types (Davies et al. 1999; Kelley et al. 2003). It has been postulated based on previous work (Morales and Wang 2002; Sudweeks et al. 2002) that the heteromeric form of the receptor was not expressed in the central nervous system (CNS). However, a follow-up study by Doucet et al. (2007) showed cortical expression of the 5-HT3b subunit using a polyclonal antibody targeted to the intracytoplasmic loop of the 5-HT3R and demonstrated that this expression differed considerably from localization of 5-HT3aRs in previous studies. The findings of Doucet et al. underscore two important points: namely, that methodological scope of previous studies investigating 5-HT3R expression was too limited to detect 5-HT3b-containing serotonin receptors. Second, the lack of the expected anatomical overlap between 5-HT3b and 5-HT3a receptor subunits in their findings suggests that the previous studies may have inadvertently overlooked a population of heteromeric 5-HT3R-containing cortical neurons. The findings of Doucet et al. are consistent with another study that supports the existence of heteromeric 5-HT3Rs in rodent neurons (Hanna et al. 2000). Lastly, we note that early studies that confirmed 5-HT3R expression on cortical interneurons (Jakab and Goldman-Rakic 2000; Morales and Wang 2002) used in situ hybridization and immunohistochemistry to find overlap between markers of inhibitory interneurons and 5-HT3Rs, but did not rigorously investigate overlap with any markers of pyramidal neurons, thus limiting the reach of their conclusions that 5-HT3Rs are expressed exclusively on interneurons. Given these caveats, we hold that previous studies leave the possibility open that there are a subset of 5-HT3Rs, likely to be heteromeric, expressed on cortical PCs. Our findings in Fig. 1 provide another compelling piece of evidence in support of this idea.

An important finding reported herein is that the synaptic noise generated by 5-HT enhances cortical network activity. That noise can enhance network activity may seem counterintuitive, yet it has been explored thoroughly in numerous nonlinear dynamic systems, including neurons (McDonnell and Ward 2011; Stacey and Durand 2001). Importantly, synaptic noise can enhance not only network activity, but also network performance, specifically in the context of encoding information (Ermentrout et al. 2008; Puzerey and Galán 2014). Probably the clearest example is stochastic resonance in which the detection of subthreshold periodic inputs to a nonlinear system can be enhanced with the introduction of noise. More broadly, a variety of dynamic phenomena in which noise promotes transitions between different system states is referred to as stochastic facilitation (McDonnell and Ward 2011). A novel finding of our study is that synaptic noise provided by 5-HT3Rs promotes transitions in a bistable network, moving between quiescent and active states. This finding is consistent with theoretical work implicating synaptic noise in the generation of epileptiform oscillations (Stacey et al. 2009). Whether other sources of noise modulate network dynamics remains an open question. We note, for instance, that previous work has shown that 5-HT enhances local glutamatergic transmission in recurrent cortical circuits (Aghajanian and Marek 1999; Beique et al. 2004, 2007). Thus determining the contribution of other neurotransmitters to synaptic noise and network activity will be useful in determining whether stochastic facilitation occurs as a general phenomenon of fast neurotransmission.

The notion that neuromodulation plays an active role in transforming network behavior has been explored thoroughly in the invertebrate CNS, particularly the crustacean stomatogastric system (Marder and Thirumalai 2002). Consequently, several fundamental principles governing network function were brought to light. An indispensable principle to our understanding was that networks, while constrained by the anatomical architecture, exhibit highly dynamic functional connectivity (Getting 1989; Marder and Thirumalai 2002). In short, the concerted behavior of neuronal networks operating within a defined anatomical circuit can be reconfigured with neuromodulation through changes in cellular, synaptic, or network properties. Our work shows that elevating endogenous cortical 5-HT leads to enhanced signaling through 5-HT2Rs, resulting in increased excitatory synaptic transmission during network activity and the emergence of fast-run oscillations. Although previous reports have demonstrated that endogenous 5-HT may modulate network oscillations (Celada et al. 2008; Puig et al. 2010), our work reveals the role of 5-HT as facilitating the emergence of distinct cortical dynamics. While we provide a network mechanism for the emergence of epileptiform fast runs under elevated 5-HT tone, the cellular cascades downstream of 5-HT2R activation responsible for the enhancement of synaptic excitation require elucidation. 5- HT2Rs have distinct downstream targets in cortical neurons, including NMDA receptors (Rahman and Neuman 1993), GABAA receptors (Huidobro-Toro et al. 1996), Ca2+-activated K+ channels (Villalobos et al. 2005), and M-channels (Tanaka and North 1993). Determining the targets responsible for enhanced network responses will be important in understanding how changes in cellular properties can lead to transformation of network activity. One could then use computational models to test the robustness of the network dynamics to changes in these parameters and determine at which parameter boundary transitions occur between states. It may also be possible that correlated variation in synaptic or membrane conductances may yield similar network behavior (Grashow et al. 2010; Marder 2011; Prinz et al. 2003). Given the prediction made by our computational model, the potassium currents underlying the slow afterhyperpolarization may be a likely effector downstream of 5-HT2Rs underlying generation of fast runs, although the enhancement of excitatory synaptic coupling in vitro suggests that NMDA receptors may play a role as well.

Previous reports have suggested that FLX suppresses intrinsic cortical microcircuits in slices of nonepileptic human PFC (Komlosi et al. 2012). While this finding is certainly relevant for understanding how FLX affects sparsely active cortical microcircuits, it stands in contrast to our findings that FLX enhances the activity of a partially disinhibited cortical network. This discrepancy may be attributable to several factors, including the following: 1) the use of a disinhibited slice in which the release of endogenous 5-HT is likely to be much higher during active states; 2) using somatosensory instead of PFC slices, which have different 5-HT receptor densities (Blue et al. 1988; Weber and Andrade 2010); and 3) comparing effects of FLX on sparse vs. global and synchronized cortical activation, the relationship between which is ambiguous. Another important consideration is that elevating endogenous 5-HT is one of several ways in which the balance between excitation and inhibition can be shifted to elicit fast-run oscillations. For instance, Castro-Alamancos and Rigas (2002) have shown that partial blockade of GABAA receptors in cortical slices is sufficient to elicit PDS but not fast-run activity, while coadministration with GABAB antagonists generates fast runs, which, as the authors argued, resulted from the unmasking of recurrent excitatory synaptic activity in the superficial cortical layers. In support of this idea, we posit that elevated cortical 5-HT enhances synaptic excitation during network activity, thereby promoting the expression of fast-run oscillations.

Our study focused exclusively on changes in excitatory drive to the PCs of the cortex under conditions where intrinsic cortical inhibition is altered. Therefore, our interpretation of the results above must be confined to the sphere of cortical function under conditions in which inhibition is diminished, such as those in which epileptiform activity emanates from such an imbalance. Nevertheless, it is important to place our results in the context of the present literature of 5-HT function on cortical circuits in which inhibition is intact. Although there are several comprehensive reviews on this topic (Andrade 2011; Celada et al. 2013; Nakamura and Wong-Lin 2014), we will briefly discuss the main principles gathered from past investigations. It has become increasingly clear that making general claims about 5-HT's role in cortical circuits is far from trivial. This difficulty arises from the heterogeneity in regional, laminar, cellular, and subcellular serotonin receptor expression (Amargos-Bosch et al. 2004; Blue et al. 1988; Jakab and Goldman-Rakic 2000; Santana et al. 2004; Weber and Andrade 2010). It has been understood, however, that the most frequent responses of cortical neurons to 5-HT are 5-HT1 receptor-mediated hyperpolarizations and 5-HT2R-mediated slow depolarizations (Araneda and Andrade 1991; Tanaka and North 1993). The former effect is mediated by activation of outward potassium currents mediated by G protein-coupled inwardly rectifying potassium channels (Luscher et al. 1997), while the latter is attributed to inhibition of a slow outward M-type potassium current (Tanaka and North 1993). 5-HT1 receptors are typically expressed at the axon hillock, where they are poised to regulate neuronal output, while 5-HT2Rs are expressed along the apical dendrite, where they can modulate neuronal gain in response to synaptic inputs (Amargos-Bosch et al. 2004; Zhang and Arsenault 2005). Often neurons expressing both receptors can have either facilitation or suppression of firing, depending on the site of stimulation in the DRN, the afferent source of serotonergic fibers innervating the forebrain, suggesting that precise circuits underlie the direction of the cortical response to 5-HT (Amargos-Bosch et al. 2004). The actions of serotonin receptors extend beyond modulation of cell-intrinsic properties to the level of synaptic interactions. It is by now well established that 5-HT2Rs enhance spontaneous postsynaptic glutamatergic currents in cortical neurons, a process attributed to the enhancement of activity in intrinsic cortical circuits by 5-HT (Beique et al. 2007; Lambe et al. 2000). 5-HT also modulates the activity of inhibitory interneurons via excitation by 5-HT3Rs and 5-HT2Rs (Puig et al. 2004; Zhou and Hablitz 1999), although interneurons expressing these two receptors may have distinct molecular, anatomical, and functional profiles. Activation of 5-HT2Rs on interneurons leads to sustained enhancement of spontaneous inhibitory postsynaptic currents onto pyramidal neurons, while activation of cortical interneurons through 5-HT3Rs leads to transient increases of inhibitory currents on PCs (Zhou and Hablitz 1999). The action of 5-HT goes as far as modulating the concerted activities of ensembles of cortical neurons. Puig et al. (2010) showed that stimulating the DRN and recording local field potentials in the PFC of anesthetized rodents leads to acceleration of the cortical slow oscillation (< 2 Hz) in a 5-HT2R-dependent manner. They also demonstrated with the same paradigm that inhibition of 5-HT1 receptors increased cortical gamma (30–80 Hz) oscillations, while 5-HT2R inhibition decreased their power. Our results find agreement with this work in that our experiments show a facilitating effect of 5-HT2Rs and a suppressive effect of 5-HT1 receptors on cortical network activity. Nevertheless, it is important to draw the distinction between the role of 5-HT as a modulator of cortical dynamics, as shown by Puig et al., and the role of 5-HT as a facilitator to the emergence of said dynamics. Furthermore, given the strict focus on the effects of 5-HT on pyramidal neurons in our study, it will be important to determine the role of inhibitory cortical interneurons in the emergence of oscillatory cortical dynamics and how their activity is shaped by altered 5-HT tone.

The transition between PDS and fast-run activity is not an artifact of the disinhibited slice. The PDS is a direct intracellular correlate of the interictal spike that often precedes epileptic seizures and is the most basic unit of epileptiform activity (McCormick and Contreras 2001). Fast runs have been demonstrated in disinhibited rat cortex (Castro-Alamancos 2000), during epileptic seizures in cats (Timofeev et al. 1998), and are an electrographic signature of epileptic seizures in children with Lennox-Gastaut syndrome, a childhood-onset encephalopathy which comprises ∼10% of all childhood epilepsies (Camfield 2011). Therefore, taking into consideration that 5-HT2R blockade abolishes fast runs in vitro, increases seizure threshold and delays the onset of electrographic fast runs in vivo lends support to the idea that excessive 5-HT in the CNS facilitates the onset of epileptiform network dynamics. These findings are in line with reports supporting 5-HT's proconvulsive effects (Bercovici et al. 2006; Freitas et al. 2006; O'Dell et al. 2000; Wada et al. 1992), but stands in opposition to others who claim that central 5-HT is anticonvulsive (Bagdy et al. 2007; Yan et al. 1995). This controversy can be attributed to the lack of consistent seizure paradigms, animal models, or pharmacological agents employed by different investigators (Loscher et al. 1990). Importantly, the studies mentioned above lack a detailed mechanism for how 5-HT may modulate epileptic seizures. Our results clearly support a proconvulsive role for enhanced 5-HT signaling by providing a mechanistic description for how changes in synaptic noise and excitatory coupling can lead to epileptiform network dynamics. An important subtlety in the interpretation of our in vitro findings is that 5-HT2R activation alone is insufficient to generate fast runs: the cortex must be partially disinhibited. In other terms, the cortical network must be close to the border of a transition between two states (i.e., PDS and fast runs) near which a shift in favor of more excitation is sufficient to push the network into an epileptiform regime. This subtlety highlights the role of 5-HT neither as an initiator nor as a modulator of epileptiform oscillations, but as a facilitator for their emergence. In the context of human epileptic seizures, our findings imply that 5-HT2R blockade may prove to be therapeutic for epileptic patients in general and, in particular, for those treated with SSRIs, which are often prescribed to patients comorbid for epilepsy and depression (Kanner 2003). Although the association between SSRIs and epileptic seizures in humans remains anecdotal, largely correlative, and confounded by factors such as coadministration of SSRIs with anti-epileptic drugs (Braitberg and Curry 1995; Gross et al. 1998; Pisani et al. 1999; Prasher 1993; Thome-Souza et al. 2007), there is substantial evidence for a proconvulsive role of FLX in animal models of epileptic seizures and epilepsy (Ferrero et al. 2005; Macedo et al. 2004; Morita et al. 2005; Raju et al. 1999; Zienowicz et al. 2005). Furthermore, our findings may be relevant for other neurological disorders in which 5-HT signaling and network dynamics are altered, such as certain cases of autism (Veenstra-VanderWeele and Blakely 2012) and schizophrenia (Aghajanian and Marek 1999).

GRANTS

This work was supported by The Ruth L. Kirschstein National Research Award NS067431 (P. A. Puzerey), The Mt. Sinai Health Care Foundation, The Alfred P. Sloan Foundation, and The Hartwell Foundation (R. F. Galán).

DISCLOSURES

No conflicts of interest, financial or otherwise, are declared by the author(s).

AUTHOR CONTRIBUTIONS

Author contributions: P.A.P. and R.F.G. conception and design of research; P.A.P. and M.J.D. performed experiments; P.A.P. and R.F.G. analyzed data; P.A.P. and R.F.G. interpreted results of experiments; P.A.P. and R.F.G. prepared figures; P.A.P. and R.F.G. drafted manuscript; P.A.P. and R.F.G. edited and revised manuscript; P.A.P., M.J.D., and R.F.G. approved final version of manuscript.

ACKNOWLEDGMENTS

We thank Trygve R. Dolber for assistance with preliminary computational studies and Yenan Zhu for assistance with animal care. We thank David Nethery for assistance with EEG electrode implantation surgeries. We also thank Drs. Evan S. Deneris and Lynn T. Landmesser for helpful suggestions on the manuscript. In addition, we thank Dr. Gary Landreth's laboratory for the use of their imaging setup. Computational simulations for Fig. 4E were performed in parallel on the High Performance Computing Cluster at Case Western Reserve University.

REFERENCES

  1. Aghajanian GK, Marek GJ. Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release. Brain Res 825: 161–171, 1999. [DOI] [PubMed] [Google Scholar]
  2. Agmon A, Connors BW. Thalamocortical responses of mouse somatosensory (barrel) cortex in vitro. Neuroscience 41: 365–379, 1991. [DOI] [PubMed] [Google Scholar]
  3. Amargos-Bosch M, Bortolozzi A, Puig MV, Serrats J, Adell A, Celada P, Toth M, Mengod G, Artigas F. Co-expression and in vivo interaction of serotonin 1A and serotonin 2A receptors in pyramidal neurons of prefrontal cortex. Cereb Cortex 14: 281–299, 2004. [DOI] [PubMed] [Google Scholar]
  4. Andrade R. Serotonergic regulation of neuronal excitability in the prefrontal cortex. Neuropharmacology 61: 382–386, 2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Andrade R, Foehring RC, Tzingounis AV. The calcium-activated slow AHP: cutting through the Gordian knot. Front Cell Neurosci 6: 47, 2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Araneda R, Andrade R. 5-Hydroxytryptamine2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience 40: 399–412, 1991. [DOI] [PubMed] [Google Scholar]
  7. Bagdy G, Kecskemeti V, Riba P, Jakus R. Serotonin and epilepsy. J Neurochem 100: 857–873, 2007. [DOI] [PubMed] [Google Scholar]
  8. Beique JC, Chapin-Penick EM, Mladenovic L, Andrade R. Serotonergic facilitation of synaptic activity in the developing rat prefrontal cortex. J Physiol 556: 739–754, 2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Beique JC, Imad M, Mladenovic L, Gingrich JA, Andrade R. Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex. Proc Natl Acad Sci U S A 104: 9870–9875, 2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bercovici E, Cortez MA, Wang X, Snead OC., 3rd. Serotonin depletion attenuates AY-9944-mediated atypical absence seizures. Epilepsia 47: 240–246, 2006. [DOI] [PubMed] [Google Scholar]
  11. Berkeley JL, Decker MJ, Levey AI. The role of muscarinic acetylcholine receptor-mediated activation of extracellular signal-regulated kinase 1/2 in pilocarpine-induced seizures. J Neurochem 82: 192–201, 2002. [DOI] [PubMed] [Google Scholar]
  12. Blue ME, Yagaloff KA, Mamounas LA, Hartig PR, Molliver ME. Correspondence between 5-HT2 receptors and serotonergic axons in rat neocortex. Brain Res 453: 315–328, 1988. [DOI] [PubMed] [Google Scholar]
  13. Bolo NR, Hode Y, Nedelec JF, Laine E, Wagner G, Macher JP. Brain pharmacokinetics and tissue distribution in vivo of fluvoxamine and fluoxetine by fluorine magnetic resonance spectroscopy. Neuropsychopharmacology 23: 428–438, 2000. [DOI] [PubMed] [Google Scholar]
  14. Braitberg G, Curry SC. Seizure after isolated fluoxetine overdose. Ann Emerg Med 26: 234–237, 1995. [DOI] [PubMed] [Google Scholar]
  15. Brown AM, Hope AG, Lambert JJ, Peters JA. Ion permeation and conduction in a human recombinant 5-HT3 receptor subunit (h5-HT3A). J Physiol 507: 653–665, 1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Burns SP, Xing D, Shapley RM. Is gamma-band activity in the local field potential of V1 cortex a “clock” or filtered noise? J Neurosci 31: 9658–9664, 2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Buzsaki G, Draguhn A. Neuronal oscillations in cortical networks. Science 304: 1926–1929, 2004. [DOI] [PubMed] [Google Scholar]
  18. Camfield PR. Definition and natural history of Lennox-Gastaut syndrome. Epilepsia 52, Suppl 5: 3–9, 2011. [DOI] [PubMed] [Google Scholar]
  19. Castro-Alamancos MA. Origin of synchronized oscillations induced by neocortical disinhibition in vivo. J Neurosci 20: 9195–9206, 2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Castro-Alamancos MA, Rigas P. Synchronized oscillations caused by disinhibition in rodent neocortex are generated by recurrent synaptic activity mediated by AMPA receptors. J Physiol 542: 567–581, 2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Celada P, Puig MV, Artigas F. Serotonin modulation of cortical neurons and networks. Front Integr Neurosci 7: 25, 2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Celada P, Puig MV, Diaz-Mataix L, Artigas F. The hallucinogen DOI reduces low-frequency oscillations in rat prefrontal cortex: reversal by antipsychotic drugs. Biol Psychiatry 64: 392–400, 2008. [DOI] [PubMed] [Google Scholar]
  23. Chagnac-Amitai Y, Connors BW. Synchronized excitation and inhibition driven by intrinsically bursting neurons in neocortex. J Neurophysiol 62: 1149–1162, 1989. [DOI] [PubMed] [Google Scholar]
  24. Davies PA, Pistis M, Hanna MC, Peters JA, Lambert JJ, Hales TG, Kirkness EF. The 5-HT3B subunit is a major determinant of serotonin-receptor function. Nature 397: 359–363, 1999. [DOI] [PubMed] [Google Scholar]
  25. Destexhe A, Rudolph M, Fellous JM, Sejnowski TJ. Fluctuating synaptic conductances recreate in vivo-like activity in neocortical neurons. Neuroscience 107: 13–24, 2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Doucet E, Latremoliere A, Darmon M, Hamon M, Emerit MB. Immunolabelling of the 5-HT 3B receptor subunit in the central and peripheral nervous systems in rodents. Eur J Neurosci 26: 355–366, 2007. [DOI] [PubMed] [Google Scholar]
  27. Dougherty JP, Aloyo VJ. Pharmacological and behavioral characterization of the 5-HT2A receptor in C57BL/6N mice. Psychopharmacology (Berl) 215: 581–593, 2011. [DOI] [PubMed] [Google Scholar]
  28. Economo MN, White JA. Membrane properties and the balance between excitation and inhibition control gamma-frequency oscillations arising from feedback inhibition. PLoS Comput Biol 8: e1002354, 2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ermentrout GB, Galán RF, Urban NN. Reliability, synchrony and noise. Trends Neurosci 31: 428–434, 2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Espinosa F, Kavalali ET. NMDA receptor activation by spontaneous glutamatergic neurotransmission. J Neurophysiol 101: 2290–2296, 2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Fernandez FR, Malerba P, Bressloff PC, White JA. Entorhinal stellate cells show preferred spike phase-locking to theta inputs that is enhanced by correlations in synaptic activity. J Neurosci 33: 6027–6040, 2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Ferrero AJ, Cereseto M, Reines A, Bonavita CD, Sifonios LL, Rubio MC, Wikinski SI. Chronic treatment with fluoxetine decreases seizure threshold in naive but not in rats exposed to the learned helplessness paradigm: correlation with the hippocampal glutamate release. Prog Neuropsychopharmacol Biol Psychiatry 29: 678–686, 2005. [DOI] [PubMed] [Google Scholar]
  33. Fink KB, Gothert M. 5-HT receptor regulation of neurotransmitter release. Pharmacol Rev 59: 360–417, 2007. [DOI] [PubMed] [Google Scholar]
  34. Freitas RM, Sousa FC, Viana GS, Fonteles MM. Effect of gabaergic, glutamatergic, antipsychotic and antidepressant drugs on pilocarpine-induced seizures and status epilepticus. Neurosci Lett 408: 79–83, 2006. [DOI] [PubMed] [Google Scholar]
  35. Frohlich F, Sejnowski TJ, Bazhenov M. Network bistability mediates spontaneous transitions between normal and pathological brain states. J Neurosci 30: 10734–10743, 2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Getting PA. Emerging principles governing the operation of neural networks. Annu Rev Neurosci 12: 185–204, 1989. [DOI] [PubMed] [Google Scholar]
  37. Gil Z, Connors BW, Amitai Y. Differential regulation of neocortical synapses by neuromodulators and activity. Neuron 19: 679–686, 1997. [DOI] [PubMed] [Google Scholar]
  38. Grashow R, Brookings T, Marder E. Compensation for variable intrinsic neuronal excitability by circuit-synaptic interactions. J Neurosci 30: 9145–9156, 2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Gross R, Dannon PN, Lepkifker E, Zohar J, Kotler M. Generalized seizures caused by fluoxetine overdose. Am J Emerg Med 16: 328–329, 1998. [DOI] [PubMed] [Google Scholar]
  40. Gutnick MJ, Connors BW, Prince DA. Mechanisms of neocortical epileptogenesis in vitro. J Neurophysiol 48: 1321–1335, 1982. [DOI] [PubMed] [Google Scholar]
  41. Hablitz JJ. Picrotoxin-induced epileptiform activity in hippocampus: role of endogenous versus synaptic factors. J Neurophysiol 51: 1011–1027, 1984. [DOI] [PubMed] [Google Scholar]
  42. Hanna MC, Davies PA, Hales TG, Kirkness EF. Evidence for expression of heteromeric serotonin 5-HT(3) receptors in rodents. J Neurochem 75: 240–247, 2000. [DOI] [PubMed] [Google Scholar]
  43. Hansel D. Synchronized chaos in local cortical circuits. Int J Neural Syst 7: 403–415, 1996. [DOI] [PubMed] [Google Scholar]
  44. Hasenstaub A, Shu Y, Haider B, Kraushaar U, Duque A, McCormick DA. Inhibitory postsynaptic potentials carry synchronized frequency information in active cortical networks. Neuron 47: 423–435, 2005. [DOI] [PubMed] [Google Scholar]
  45. Huidobro-Toro JP, Valenzuela CF, Harris RA. Modulation of GABAA receptor function by G protein-coupled 5-HT2C receptors. Neuropharmacology 35: 1355–1363, 1996. [DOI] [PubMed] [Google Scholar]
  46. Jakab RL, Goldman-Rakic PS. Segregation of serotonin 5-HT2A and 5-HT3 receptors in inhibitory circuits of the primate cerebral cortex. J Comp Neurol 417: 337–348, 2000. [DOI] [PubMed] [Google Scholar]
  47. Kaczmarek LK, Levitan IB. Neuromodulation: The Biochemical Control of Neuronal Excitability. New York: Oxford University Press, 1987, p. 6. [Google Scholar]
  48. Kanner AM. Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment. Biol Psychiatry 54: 388–398, 2003. [DOI] [PubMed] [Google Scholar]
  49. Kelley SP, Dunlop JI, Kirkness EF, Lambert JJ, Peters JA. A cytoplasmic region determines single-channel conductance in 5-HT3 receptors. Nature 424: 321–324, 2003. [DOI] [PubMed] [Google Scholar]
  50. Kolind J, Hounsgaard J, Berg RW. Opposing effects of intrinsic conductance and correlated synaptic input on V-fluctuations during network activity. Front Comput Neurosci 6: 40, 2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Komlosi G, Molnar G, Rozsa M, Olah S, Barzo P, Tamas G. Fluoxetine (prozac) and serotonin act on excitatory synaptic transmission to suppress single layer 2/3 pyramidal neuron-triggered cell assemblies in the human prefrontal cortex. J Neurosci 32: 16369–16378, 2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Lambe EK, Goldman-Rakic PS, Aghajanian GK. Serotonin induces EPSCs preferentially in layer V pyramidal neurons of the frontal cortex in the rat. Cereb Cortex 10: 974–980, 2000. [DOI] [PubMed] [Google Scholar]
  53. Lee S, Hjerling-Leffler J, Zagha E, Fishell G, Rudy B. The largest group of superficial neocortical GABAergic interneurons expresses ionotropic serotonin receptors. J Neurosci 30: 16796–16808, 2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Lee WL, Hablitz JJ. Initiation of epileptiform activity by excitatory amino acid receptors in the disinhibited rat neocortex. J Neurophysiol 65: 87–95, 1991. [DOI] [PubMed] [Google Scholar]
  55. Lefort S, Tomm C, Floyd Sarria JC, Petersen CC. The excitatory neuronal network of the C2 barrel column in mouse primary somatosensory cortex. Neuron 61: 301–316, 2009. [DOI] [PubMed] [Google Scholar]
  56. Loscher W, Nolting B, Fassbender CP. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. I. The influence of administration vehicles. Epilepsy Res 7: 173–181, 1990. [DOI] [PubMed] [Google Scholar]
  57. Luscher C, Jan LY, Stoffel M, Malenka RC, Nicoll RA. G protein-coupled inwardly rectifying K+ channels (GIRKs) mediate postsynaptic but not presynaptic transmitter actions in hippocampal neurons. Neuron 19: 687–695, 1997. [DOI] [PubMed] [Google Scholar]
  58. Macedo DS, Santos RS, Belchior LD, Neto MA, Vasconcelos SM, Lima VT, Fonteles MM, Viana GS, de Sousa FC. Effect of anxiolytic, antidepressant, and antipsychotic drugs on cocaine-induced seizures and mortality. Epilepsy Behav 5: 852–856, 2004. [DOI] [PubMed] [Google Scholar]
  59. Maffei A, Turrigiano GG. Multiple modes of network homeostasis in visual cortical layer 2/3. J Neurosci 28: 4377–4384, 2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Marder E. Neuromodulation of neuronal circuits: back to the future. Neuron 76: 1–11, 2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Marder E. Variability, compensation, and modulation in neurons and circuits. Proc Natl Acad Sci U S A 108, Suppl 3: 15542–15548, 2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Marder E, Thirumalai V. Cellular, synaptic and network effects of neuromodulation. Neural Netw 15: 479–493, 2002. [DOI] [PubMed] [Google Scholar]
  63. McCormick DA, Contreras D. On the cellular and network bases of epileptic seizures. Annu Rev Physiol 63: 815–846, 2001. [DOI] [PubMed] [Google Scholar]
  64. McDonnell MD, Ward LM. The benefits of noise in neural systems: bridging theory and experiment. Nat Rev Neurosci 12: 415–426, 2011. [DOI] [PubMed] [Google Scholar]
  65. Morales M, Wang SD. Differential composition of 5-hydroxytryptamine3 receptors synthesized in the rat CNS and peripheral nervous system. J Neurosci 22: 6732–6741, 2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Morita K, Hamamoto M, Arai S, Kitayama S, Irifune M, Kawahara M, Kihira K, Dohi T. Inhibition of serotonin transporters by cocaine and meprylcaine through 5-TH2C receptor stimulation facilitates their seizure activities. Brain Res 1057: 153–160, 2005. [DOI] [PubMed] [Google Scholar]
  67. Nakamura K, Wong-Lin K. Functions and computational principles of serotonergic and related systems at multiple scales. Front Integr Neurosci 8: 23, 2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Nichols DE, Nichols CD. Serotonin receptors. Chem Rev 108: 1614–1641, 2008. [DOI] [PubMed] [Google Scholar]
  69. O'Dell LE, Kreifeldt MJ, George FR, Ritz MC. The role of serotonin(2) receptors in mediating cocaine-induced convulsions. Pharmacol Biochem Behav 65: 677–681, 2000. [DOI] [PubMed] [Google Scholar]
  70. Otsu Y, Murphy TH. Miniature transmitter release: accident of nature or careful design? Sci STKE 2003: pe54, 2003. [DOI] [PubMed] [Google Scholar]
  71. Pankratov Y, Lalo U, Verkhratsky A, North RA. Quantal release of ATP in mouse cortex. J Gen Physiol 129: 257–265, 2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Papale LA, Makinson CD, Christopher Ehlen J, Tufik S, Decker MJ, Paul KN, Escayg A. Altered sleep regulation in a mouse model of SCN1A-derived genetic epilepsy with febrile seizures plus (GEFS+). Epilepsia 54: 625–634, 2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Parga N, Abbott LF. Network model of spontaneous activity exhibiting synchronous transitions between up and down states. Front Neurosci 1: 57–66, 2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Parks CL, Robinson PS, Sibille E, Shenk T, Toth M. Increased anxiety of mice lacking the serotonin1A receptor. Proc Natl Acad Sci U S A 95: 10734–10739, 1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Petersen CC, Grinvald A, Sakmann B. Spatiotemporal dynamics of sensory responses in layer 2/3 of rat barrel cortex measured in vivo by voltage-sensitive dye imaging combined with whole-cell voltage recordings and neuron reconstructions. J Neurosci 23: 1298–1309, 2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Pisani F, Spina E, Oteri G. Antidepressant drugs and seizure susceptibility: from in vitro data to clinical practice. Epilepsia 40, Suppl 10: S48–S56, 1999. [DOI] [PubMed] [Google Scholar]
  77. Poulet JF, Petersen CC. Internal brain state regulates membrane potential synchrony in barrel cortex of behaving mice. Nature 454: 881–885, 2008. [DOI] [PubMed] [Google Scholar]
  78. Prasher VP. Seizures associated with fluoxetine therapy. Seizure 2: 315–317, 1993. [DOI] [PubMed] [Google Scholar]
  79. Prinz AA, Billimoria CP, Marder E. Alternative to hand-tuning conductance-based models: construction and analysis of databases of model neurons. J Neurophysiol 90: 3998–4015, 2003. [DOI] [PubMed] [Google Scholar]
  80. Pucilowska J, Puzerey PA, Karlo JC, Galán RF, Landreth GE. Disrupted ERK signaling during cortical development leads to abnormal progenitor proliferation, neuronal and network excitability and behavior, modeling human neuro-cardio-facial-cutaneous and related syndromes. J Neurosci 32: 8663–8677, 2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Puig MV, Gulledge AT. Serotonin and prefrontal cortex function: neurons, networks, and circuits. Mol Neurobiol 44: 449–464, 2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Puig MV, Santana N, Celada P, Mengod G, Artigas F. In vivo excitation of GABA interneurons in the medial prefrontal cortex through 5-HT3 receptors. Cereb Cortex 14: 1365–1375, 2004. [DOI] [PubMed] [Google Scholar]
  83. Puig MV, Watakabe A, Ushimaru M, Yamamori T, Kawaguchi Y. Serotonin modulates fast-spiking interneuron and synchronous activity in the rat prefrontal cortex through 5-HT1A and 5-HT2A receptors. J Neurosci 30: 2211–2222, 2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Puzerey PA, Galán RF. On how correlations between excitatory and inhibitory synaptic inputs maximize the information rate of neuronal firing. Front Comput Neurosci 8: 59, 2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Rahman S, Neuman RS. Activation of 5-HT2 receptors facilitates depolarization of neocortical neurons by N-methyl-d-aspartate. Eur J Pharmacol 231: 347–354, 1993. [DOI] [PubMed] [Google Scholar]
  86. Raju SS, Noor AR, Gurthu S, Giriyappanavar CR, Acharya SB, Low HC, Quah SH. Effect of fluoxetine on maximal electroshock seizures in mice: acute vs. chronic administration. Pharmacol Res 39: 451–454, 1999. [DOI] [PubMed] [Google Scholar]
  87. Roerig B, Nelson DA, Katz LC. Fast synaptic signaling by nicotinic acetylcholine and serotonin 5-HT3 receptors in developing visual cortex. J Neurosci 17: 8353–8362, 1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Santana N, Bortolozzi A, Serrats J, Mengod G, Artigas F. Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb Cortex 14: 1100–1109, 2004. [DOI] [PubMed] [Google Scholar]
  89. Satake T, Mitani H, Nakagome K, Kaneko K. Individual and additive effects of neuromodulators on the slow components of afterhyperpolarization currents in layer V pyramidal cells of the rat medial prefrontal cortex. Brain Res 1229: 47–60, 2008. [DOI] [PubMed] [Google Scholar]
  90. Shadlen MN, Newsome WT. The variable discharge of cortical neurons: implications for connectivity, computation, and information coding. J Neurosci 18: 3870–3896, 1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Stacey WC, Durand DM. Synaptic noise improves detection of subthreshold signals in hippocampal CA1 neurons. J Neurophysiol 86: 1104–1112, 2001. [DOI] [PubMed] [Google Scholar]
  92. Stacey WC, Lazarewicz MT, Litt B. Synaptic noise and physiological coupling generate high-frequency oscillations in a hippocampal computational model. J Neurophysiol 102: 2342–2357, 2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Steriade M, Amzica F, Neckelmann D, Timofeev I. Spike-wave complexes and fast components of cortically generated seizures. II. Extra- and intracellular patterns. J Neurophysiol 80: 1456–1479, 1998. [DOI] [PubMed] [Google Scholar]
  94. Sudweeks SN, Hooft JA, Yakel JL. Serotonin 5-HT(3) receptors in rat CA1 hippocampal interneurons: functional and molecular characterization. J Physiol 544: 715–726, 2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Sung KW, Engel SR, Allan AM, Lovinger DM. 5-HT(3) receptor function and potentiation by alcohols in frontal cortex neurons from transgenic mice overexpressing the receptor. Neuropharmacology 39: 2346–2351, 2000. [DOI] [PubMed] [Google Scholar]
  96. Sutton MA, Wall NR, Aakalu GN, Schuman EM. Regulation of dendritic protein synthesis by miniature synaptic events. Science 304: 1979–1983, 2004. [DOI] [PubMed] [Google Scholar]
  97. Tanaka E, North RA. Actions of 5-hydroxytryptamine on neurons of the rat cingulate cortex. J Neurophysiol 69: 1749–1757, 1993. [DOI] [PubMed] [Google Scholar]
  98. Thome-Souza MS, Kuczynski E, Valente KD. Sertraline and fluoxetine: safe treatments for children and adolescents with epilepsy and depression. Epilepsy Behav 10: 417–425, 2007. [DOI] [PubMed] [Google Scholar]
  99. Thomson AM, Lamy C. Functional maps of neocortical local circuitry. Front Neurosci 1: 19–42, 2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Timofeev I, Grenier F, Steriade M. Spike-wave complexes and fast components of cortically generated seizures. IV. Paroxysmal fast runs in cortical and thalamic neurons. J Neurophysiol 80: 1495–1513, 1998. [DOI] [PubMed] [Google Scholar]
  101. Veenstra-VanderWeele J, Blakely RD. Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments. Neuropsychopharmacology 37: 196–212, 2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Villalobos C, Beique JC, Gingrich JA, Andrade R. Serotonergic regulation of calcium-activated potassium currents in rodent prefrontal cortex. Eur J Neurosci 22: 1120–1126, 2005. [DOI] [PubMed] [Google Scholar]
  103. Villalobos C, Foehring RC, Lee JC, Andrade R. Essential role for phosphatidylinositol 4,5-bisphosphate in the expression, regulation, and gating of the slow afterhyperpolarization current in the cerebral cortex. J Neurosci 31: 18303–18312, 2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Vucurovic K, Gallopin T, Ferezou I, Rancillac A, Chameau P, van Hooft JA, Geoffroy H, Monyer H, Rossier J, Vitalis T. Serotonin 3A receptor subtype as an early and protracted marker of cortical interneuron subpopulations. Cereb Cortex 20: 2333–2347, 2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Vyleta NP, Smith SM. Spontaneous glutamate release is independent of calcium influx and tonically activated by the calcium-sensing receptor. J Neurosci 31: 4593–4606, 2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Wada Y, Nakamura M, Hasegawa H, Yamaguchi N. Role of serotonin receptor subtype in seizures kindled from the feline hippocampus. Neurosci Lett 141: 21–24, 1992. [DOI] [PubMed] [Google Scholar]
  107. Wasser CR, Kavalali ET. Leaky synapses: regulation of spontaneous neurotransmission in central synapses. Neuroscience 158: 177–188, 2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Weber ET, Andrade R. Htr2a gene and 5-HT(2A) receptor expression in the cerebral cortex studied using genetically modified mice. Front Neurosci 4: 36, 2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Yan QS, Jobe PC, Dailey JW. Further evidence of anticonvulsant role for 5-hydroxytryptamine in genetically epilepsy-prone rats. Br J Pharmacol 115: 1314–1318, 1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Zhang ZW, Arsenault D. Gain modulation by serotonin in pyramidal neurones of the rat prefrontal cortex. J Physiol 566: 379–394, 2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Zhou FM, Hablitz JJ. Activation of serotonin receptors modulates synaptic transmission in rat cerebral cortex. J Neurophysiol 82: 2989–2999, 1999. [DOI] [PubMed] [Google Scholar]
  112. Zienowicz M, Wislowska A, Lehner M, Taracha E, Skorzewska A, Maciejak P, Plaznik A. The effect of fluoxetine in a model of chemically induced seizures–behavioral and immunocytochemical study. Neurosci Lett 373: 226–231, 2005. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurophysiology are provided here courtesy of American Physiological Society

RESOURCES